Similarly, in a mouse model of bleomycin-induced pulmonary hypertension, recombinant ACE2 treatment increased pulmonary SOD2 expression, reduced oxidative stress and attenuated development of vascular remodelling [148]. Here, SOD2 is linked to pulmonary hypertension.